JP2015528284A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015528284A5 JP2015528284A5 JP2015527637A JP2015527637A JP2015528284A5 JP 2015528284 A5 JP2015528284 A5 JP 2015528284A5 JP 2015527637 A JP2015527637 A JP 2015527637A JP 2015527637 A JP2015527637 A JP 2015527637A JP 2015528284 A5 JP2015528284 A5 JP 2015528284A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- mep
- culturing
- ahr
- conditions sufficient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 176
- 238000012258 culturing Methods 0.000 claims description 106
- 210000000135 megakaryocyte-erythroid progenitor cell Anatomy 0.000 claims description 103
- 102000003984 Aryl Hydrocarbon Receptors Human genes 0.000 claims description 66
- 108090000448 Aryl Hydrocarbon Receptors Proteins 0.000 claims description 66
- 210000003743 erythrocyte Anatomy 0.000 claims description 61
- LKTNEXPODAWWFM-UHFFFAOYSA-N 2-methyl-N-[2-methyl-4-(2-methylphenyl)azophenyl]-3-pyrazolecarboxamide Chemical compound CC1=CC=CC=C1N=NC(C=C1C)=CC=C1NC(=O)C1=CC=NN1C LKTNEXPODAWWFM-UHFFFAOYSA-N 0.000 claims description 47
- 239000000556 agonist Substances 0.000 claims description 25
- 238000004519 manufacturing process Methods 0.000 claims description 22
- 210000003593 megakaryocyte Anatomy 0.000 claims description 14
- KDDXOGDIPZSCTM-UHFFFAOYSA-N 2-[1H-indol-3-yl(oxo)methyl]-4-thiazolecarboxylic acid methyl ester Chemical compound COC(=O)C1=CSC(C(=O)C=2C3=CC=CC=C3NC=2)=N1 KDDXOGDIPZSCTM-UHFFFAOYSA-N 0.000 claims description 6
- 210000001778 pluripotent stem cell Anatomy 0.000 claims description 5
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 2
- 101001078143 Homo sapiens Integrin alpha-IIb Proteins 0.000 claims description 2
- 102100025306 Integrin alpha-IIb Human genes 0.000 claims description 2
- 239000000203 mixture Substances 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 17
- 239000002609 medium Substances 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 12
- 241000124008 Mammalia Species 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 208000007502 anemia Diseases 0.000 description 7
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 6
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 6
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 6
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 4
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 4
- 206010043554 thrombocytopenia Diseases 0.000 description 4
- 210000003311 CFU-EM Anatomy 0.000 description 3
- 102100023072 Neurolysin, mitochondrial Human genes 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 2
- 101000693922 Bos taurus Albumin Proteins 0.000 description 2
- 102100020715 Fms-related tyrosine kinase 3 ligand protein Human genes 0.000 description 2
- 101710162577 Fms-related tyrosine kinase 3 ligand protein Proteins 0.000 description 2
- 239000012580 N-2 Supplement Substances 0.000 description 2
- 239000012979 RPMI medium Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- -1 hSCF Proteins 0.000 description 2
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- 101100239628 Danio rerio myca gene Proteins 0.000 description 1
- 108010074604 Epoetin Alfa Proteins 0.000 description 1
- 206010016803 Fluid overload Diseases 0.000 description 1
- 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 description 1
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 1
- 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 102100020677 Krueppel-like factor 4 Human genes 0.000 description 1
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 1
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 1
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 description 1
- 208000002903 Thalassemia Diseases 0.000 description 1
- 102100024270 Transcription factor SOX-2 Human genes 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940089118 epogen Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261683246P | 2012-08-15 | 2012-08-15 | |
| US61/683,246 | 2012-08-15 | ||
| US13/828,357 | 2013-03-14 | ||
| US13/828,357 US9074186B2 (en) | 2012-08-15 | 2013-03-14 | Production of red blood cells and platelets from stem cells |
| PCT/US2013/055160 WO2014028749A2 (en) | 2012-08-15 | 2013-08-15 | Production of red blood cells and platelets from stem cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015528284A JP2015528284A (ja) | 2015-09-28 |
| JP2015528284A5 true JP2015528284A5 (cg-RX-API-DMAC7.html) | 2016-09-29 |
| JP6506689B2 JP6506689B2 (ja) | 2019-04-24 |
Family
ID=50100189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015527637A Active JP6506689B2 (ja) | 2012-08-15 | 2013-08-15 | 幹細胞からの赤血球および血小板の生成 |
Country Status (9)
| Country | Link |
|---|---|
| US (6) | US9074186B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2909313B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6506689B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104919041B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013302512B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015003250B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2882030C (cg-RX-API-DMAC7.html) |
| IN (1) | IN2015DN01402A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014028749A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201210857D0 (en) | 2012-06-19 | 2012-08-01 | Cambridge Entpr Ltd | Transcription factor mediated programming towards megakaryocytes |
| US9074186B2 (en) | 2012-08-15 | 2015-07-07 | Boston Medical Center Corporation | Production of red blood cells and platelets from stem cells |
| ES2896354T3 (es) | 2012-12-21 | 2022-02-24 | Astellas Inst For Regenerative Medicine | Métodos para la producción de plaquetas a partir de células madre pluripotentes |
| WO2014138485A1 (en) * | 2013-03-08 | 2014-09-12 | Irm Llc | Ex vivo production of platelets from hematopoietic stem cells and the product thereof |
| JP6551963B2 (ja) * | 2014-05-14 | 2019-07-31 | 国立大学法人京都大学 | 巨核球前駆細胞の製造方法 |
| HK1248762A1 (zh) * | 2015-06-16 | 2018-10-19 | 国立大学法人京都大学 | 高功能性血小板的制造方法 |
| FR3039166B1 (fr) * | 2015-07-23 | 2018-10-26 | Institut National De La Sante Et De La Recherche Medicale | Progeniteurs de megacaryocytes cd34+cd41dim et leurs utilisations pour produire des plaquettes et/ou des mk portant des proplaquettes |
| JP2018535666A (ja) * | 2015-10-15 | 2018-12-06 | セルラリティ インコーポレイテッド | ナチュラルキラー細胞およびｉｌｃ３細胞ならびにそれらの使用 |
| US11713447B2 (en) | 2016-08-04 | 2023-08-01 | Icahn School Of Medicine At Mount Sinai | Production of megakaryoctye compositions and therapies for treatment of thrombocytopenia |
| US20200179341A1 (en) * | 2016-11-04 | 2020-06-11 | Ohio State Innovation Foundation | Methods and compositions for treating multiple myeloma and increasing antibody dependent cell cytotoxicity by targeting the aryl hydrocarbon receptor |
| EP3735457A4 (en) | 2018-01-05 | 2021-08-25 | Platelet Biogenesis, Inc. | COMPOSITIONS AND METHOD OF MANUFACTURING MEGAKARYOCYTE |
| WO2020006539A1 (en) | 2018-06-29 | 2020-01-02 | Platelet Biogenesis, Inc. | Compositions for drug delivery and methods of use thereof |
| CA3178252A1 (en) | 2020-05-11 | 2021-11-18 | Erytech Pharma | Red cell extracellular vesicles (rcevs) containing cargoes and methods of use and production thereof |
| CN113046310B (zh) * | 2020-12-30 | 2023-08-18 | 中国人民解放军军事科学院军事医学研究院 | 摇动培养促进造血干细胞诱导分化为巨核系细胞的培养基及方法 |
| US20230174938A1 (en) * | 2021-12-08 | 2023-06-08 | Trailhead Biosystems Inc. | Methods and compositions for generating human erythroid progenitor cells |
| WO2024018018A1 (fr) * | 2022-07-21 | 2024-01-25 | Etablissement Francais Du Sang | Utilisation d'un composé vitisine pour la production de cellules hématopoïétiques |
| CN120225661A (zh) * | 2022-11-24 | 2025-06-27 | 苏州血霁生物科技有限公司 | 一种分化血小板的方法、培养基及其应用 |
| WO2024205363A1 (ko) * | 2023-03-29 | 2024-10-03 | 주식회사 듀셀바이오테라퓨틱스 | 적혈구 및 혈소판의 제조 방법 |
| WO2025037108A2 (en) | 2023-08-15 | 2025-02-20 | Board Of Trustees Of The Leland Stanford Junior University | Modified thrombopoietin |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US4044126A (en) | 1972-04-20 | 1977-08-23 | Allen & Hanburys Limited | Steroidal aerosol compositions and process for the preparation thereof |
| GB1429184A (en) | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols |
| USRE28819E (en) | 1972-12-08 | 1976-05-18 | Syntex (U.S.A.) Inc. | Dialkylated glycol compositions and medicament preparations containing same |
| US4410545A (en) | 1981-02-13 | 1983-10-18 | Syntex (U.S.A.) Inc. | Carbonate diester solutions of PGE-type compounds |
| US4328245A (en) | 1981-02-13 | 1982-05-04 | Syntex (U.S.A.) Inc. | Carbonate diester solutions of PGE-type compounds |
| US4358603A (en) | 1981-04-16 | 1982-11-09 | Syntex (U.S.A.) Inc. | Acetal stabilized prostaglandin compositions |
| US4409239A (en) | 1982-01-21 | 1983-10-11 | Syntex (U.S.A.) Inc. | Propylene glycol diester solutions of PGE-type compounds |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5583024A (en) | 1985-12-02 | 1996-12-10 | The Regents Of The University Of California | Recombinant expression of Coleoptera luciferase |
| US5221623A (en) | 1986-07-22 | 1993-06-22 | Boyce Thompson Institute For Plant Research, Inc. | Use of bacterial luciferase structural genes for cloning and monitoring gene expression in microorganisms and for tagging and identification of genetically engineered organisms |
| US5033252A (en) | 1987-12-23 | 1991-07-23 | Entravision, Inc. | Method of packaging and sterilizing a pharmaceutical product |
| US5052558A (en) | 1987-12-23 | 1991-10-01 | Entravision, Inc. | Packaged pharmaceutical product |
| US5070012A (en) | 1988-03-30 | 1991-12-03 | The Board Of Trustees Of The Leland Stanford Junior University | Monitoring of cells and trans-activating transcription elements |
| US5683888A (en) | 1989-07-22 | 1997-11-04 | University Of Wales College Of Medicine | Modified bioluminescent proteins and their use |
| US5585112A (en) | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| IT1246382B (it) | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
| US5283179A (en) | 1990-09-10 | 1994-02-01 | Promega Corporation | Luciferase assay method |
| US5543390A (en) | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Covalent microparticle-drug conjugates for biological targeting |
| US6010715A (en) | 1992-04-01 | 2000-01-04 | Bertek, Inc. | Transdermal patch incorporating a polymer film incorporated with an active agent |
| US6024975A (en) | 1992-04-08 | 2000-02-15 | Americare International Diagnostics, Inc. | Method of transdermally administering high molecular weight drugs with a polymer skin enhancer |
| US5323907A (en) | 1992-06-23 | 1994-06-28 | Multi-Comp, Inc. | Child resistant package assembly for dispensing pharmaceutical medications |
| US6274552B1 (en) | 1993-03-18 | 2001-08-14 | Cytimmune Sciences, Inc. | Composition and method for delivery of biologically-active factors |
| US5985307A (en) | 1993-04-14 | 1999-11-16 | Emory University | Device and method for non-occlusive localized drug delivery |
| US5523092A (en) | 1993-04-14 | 1996-06-04 | Emory University | Device for local drug delivery and methods for using the same |
| US6004534A (en) | 1993-07-23 | 1999-12-21 | Massachusetts Institute Of Technology | Targeted polymerized liposomes for improved drug delivery |
| JPH09504111A (ja) | 1993-12-30 | 1997-04-22 | ザ ソールク インスチチュート フォア バイオロジカル スタディズ | Ｇａｌ４−受容体構築体の新規な使用 |
| JP3466765B2 (ja) | 1994-07-27 | 2003-11-17 | キッコーマン株式会社 | ビオチン化ホタルルシフェラーゼ、ビオチン化ホタルルシフェラーゼ遺伝子、新規な組み換え体ｄｎａ、ビオチン化ホタルルシフェラーゼの製造法及び生物発光分析法 |
| US5759542A (en) | 1994-08-05 | 1998-06-02 | New England Deaconess Hospital Corporation | Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases |
| US5660854A (en) | 1994-11-28 | 1997-08-26 | Haynes; Duncan H | Drug releasing surgical implant or dressing material |
| US5741657A (en) | 1995-03-20 | 1998-04-21 | The Regents Of The University Of California | Fluorogenic substrates for β-lactamase and methods of use |
| US5983134A (en) | 1995-04-23 | 1999-11-09 | Electromagnetic Bracing Systems Inc. | Electrophoretic cuff apparatus drug delivery system |
| US6316652B1 (en) | 1995-06-06 | 2001-11-13 | Kosta Steliou | Drug mitochondrial targeting agents |
| US6167301A (en) | 1995-08-29 | 2000-12-26 | Flower; Ronald J. | Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit |
| US6039975A (en) | 1995-10-17 | 2000-03-21 | Hoffman-La Roche Inc. | Colon targeted delivery system |
| TW345603B (en) | 1996-05-29 | 1998-11-21 | Gmundner Fertigteile Gmbh | A noise control device for tracks |
| US5985317A (en) | 1996-09-06 | 1999-11-16 | Theratech, Inc. | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
| KR100353304B1 (ko) | 1996-10-01 | 2002-09-30 | 에스알아이 인터내셔널 | 맛이 차폐된 마이크로캡슐 조성물 및 이것의 제조 방법 |
| US5955604A (en) | 1996-10-15 | 1999-09-21 | The Regents Of The University Of California | Substrates for β-lactamase and uses thereof |
| US6131570A (en) | 1998-06-30 | 2000-10-17 | Aradigm Corporation | Temperature controlling device for aerosol drug delivery |
| US5860957A (en) | 1997-02-07 | 1999-01-19 | Sarcos, Inc. | Multipathway electronically-controlled drug delivery system |
| US6120751A (en) | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
| US6060082A (en) | 1997-04-18 | 2000-05-09 | Massachusetts Institute Of Technology | Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery |
| US5948433A (en) | 1997-08-21 | 1999-09-07 | Bertek, Inc. | Transdermal patch |
| US6342220B1 (en) | 1997-08-25 | 2002-01-29 | Genentech, Inc. | Agonist antibodies |
| JP4395200B2 (ja) | 1997-10-28 | 2010-01-06 | バンドー化学株式会社 | 皮膚貼付薬シート及びそのための基材シートの製造方法 |
| US7101681B1 (en) | 1997-11-21 | 2006-09-05 | Amgen, Inc. | Nuclear hormone receptor drug screens |
| US6048736A (en) | 1998-04-29 | 2000-04-11 | Kosak; Kenneth M. | Cyclodextrin polymers for carrying and releasing drugs |
| WO2000025134A1 (en) | 1998-10-23 | 2000-05-04 | Glaxo Group Limited | Assays for ligands for nuclear receptors |
| WO2000057891A1 (en) | 1999-03-30 | 2000-10-05 | Trustees Of Boston University | Compositions and methods for producing platelets and/or proplatelets from megakaryocytes |
| US6271359B1 (en) | 1999-04-14 | 2001-08-07 | Musc Foundation For Research Development | Tissue-specific and pathogen-specific toxic agents and ribozymes |
| US6256533B1 (en) | 1999-06-09 | 2001-07-03 | The Procter & Gamble Company | Apparatus and method for using an intracutaneous microneedle array |
| US6261595B1 (en) | 2000-02-29 | 2001-07-17 | Zars, Inc. | Transdermal drug patch with attached pocket for controlled heating device |
| US6509380B1 (en) * | 2001-12-14 | 2003-01-21 | Marshall University Research Corporation | Method of treating iron overload with acetaminophen |
| BRPI0516969A (pt) | 2004-10-25 | 2008-09-30 | Cellerant Therapeutics Inc | método de preparar uma composição terapêutica, composição terapêutica, e, método de tratar um paciente humano sofrendo de hematopoiese deficiente |
| CN102231984A (zh) | 2008-10-01 | 2011-11-02 | 北卡罗来纳大学查珀尔希尔分校 | 使用选择性细胞周期蛋白依赖性激酶4/6抑制剂对抗化疗化合物的造血防护 |
| PE20100362A1 (es) | 2008-10-30 | 2010-05-27 | Irm Llc | Derivados de purina que expanden las celulas madre hematopoyeticas |
| WO2010108005A2 (en) | 2009-03-18 | 2010-09-23 | University Of Georgia Research Foundation | Novel neural progenitors from pluripotent stem cells, methods of producing same and use to produce neural cells |
| KR20180086301A (ko) | 2009-12-04 | 2018-07-30 | 스템 셀 앤드 리제너러티브 메디신 인터내셔날, 인크. | 기질 없는 조건 하에서 인간 배아줄기세포로부터 기능적 거핵구 및 혈소판의 대규모 생성 |
| US8652845B2 (en) | 2010-03-18 | 2014-02-18 | Kyoto University | Method for producing mesodermal cells by culturing under adherent conditions and without co-culture with cells from a different species in a serum-free medium |
| US10314810B2 (en) | 2010-07-27 | 2019-06-11 | Trustees Of Boston University | Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics |
| WO2012061146A1 (en) | 2010-10-25 | 2012-05-10 | The Children's Hospital Of Philadelphia | Compositions and methods for the generation of platelets and methods of use thereof |
| US9074186B2 (en) | 2012-08-15 | 2015-07-07 | Boston Medical Center Corporation | Production of red blood cells and platelets from stem cells |
-
2013
- 2013-03-14 US US13/828,357 patent/US9074186B2/en active Active
- 2013-08-15 CN CN201380053972.0A patent/CN104919041B/zh active Active
- 2013-08-15 EP EP13829847.6A patent/EP2909313B1/en active Active
- 2013-08-15 EP EP20198278.2A patent/EP3789483A1/en active Pending
- 2013-08-15 WO PCT/US2013/055160 patent/WO2014028749A2/en not_active Ceased
- 2013-08-15 BR BR112015003250-8A patent/BR112015003250B1/pt not_active IP Right Cessation
- 2013-08-15 IN IN1402DEN2015 patent/IN2015DN01402A/en unknown
- 2013-08-15 US US14/421,191 patent/US9896660B2/en active Active
- 2013-08-15 CA CA2882030A patent/CA2882030C/en active Active
- 2013-08-15 AU AU2013302512A patent/AU2013302512B2/en active Active
- 2013-08-15 JP JP2015527637A patent/JP6506689B2/ja active Active
-
2015
- 2015-06-02 US US14/729,008 patent/US10544393B2/en active Active
- 2015-06-02 US US14/729,004 patent/US9919009B2/en active Active
-
2018
- 2018-02-17 US US15/898,526 patent/US11124769B2/en active Active
-
2021
- 2021-08-20 US US17/407,349 patent/US12173320B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015528284A5 (cg-RX-API-DMAC7.html) | ||
| EP2765187B1 (en) | Method for producing megakaryocytes and/or platelets from pluripotent stem cells | |
| Zhou et al. | Engineering induced pluripotent stem cells for cancer immunotherapy | |
| Szabo et al. | Direct conversion of human fibroblasts to multilineage blood progenitors | |
| JP2022088643A (ja) | 多能性幹細胞製造システム、幹細胞の誘導方法、幹細胞の浮遊培養方法、幹細胞の浮遊培養器、人工多能性幹細胞の作製方法、及び動物細胞から特定の体細胞を作製する方法 | |
| JP7287634B2 (ja) | 精製血小板の製造方法 | |
| CA2912688C (en) | Enriched and expanded human cord blood stem cells for treatment of hematological disorders | |
| JP2022064953A (ja) | 無間質条件下におけるヒト胚性幹細胞からの機能的巨核球および血小板の大規模生成 | |
| Ayllon et al. | The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fate | |
| WO2014028749A3 (en) | Production of red blood cells and platelets from stem cells | |
| AU2016273439B2 (en) | Methods for culturing and/or differentiating hematopoietic stem cells into progenitors and uses thereof | |
| JPWO2016143836A1 (ja) | 巨核球を含む培養物の製造方法及びこれを用いた血小板の製造方法 | |
| CA3171960A1 (en) | Generating aorta-gonad-mesonephros-like hematopoietic cells from human pluripotent stem cells under a defined condition | |
| JP5597904B2 (ja) | 多能性幹細胞からの血液細胞分化に関する培養方法 | |
| Xu et al. | A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells | |
| Chang et al. | Generation and characterization of erythroid cells from human embryonic stem cells and induced pluripotent stem cells: an overview | |
| JP7570456B2 (ja) | 精製血小板の製造方法、血小板製剤の製造方法、血液製剤の製造方法、血小板保存液、血小板保存剤および血小板の保存方法 | |
| Hoggatt et al. | Hematopoietic stem and progenitor cell mobilization in mice | |
| US12091683B2 (en) | Method for producing platelets, method for producing platelet product, and method for producing blood product | |
| de Souza et al. | Advances in cellular technology in the hematology field: What have we learned so far? | |
| Cheng et al. | In vitro Haematopoietic differentiation from pluripotent stem cells or by direct lineage conversion: current advances and challenges | |
| KR20240080290A (ko) | 줄기세포에서 감마델타 t세포로의 분화 유도용 배지 조성물 및 이를 이용한 분화 방법 |